Cargando…
A pilot multi‐centre prospective randomised controlled trial of RECELL for the treatment of venous leg ulcers
Venous leg ulcers (VLUs) have a significant impact on approximately 3% of the adult population worldwide, with a mean NHS wound care cost of £7600 per VLU over 12 months. The standard care for VLUs is compression therapy, with a significant number of ulcers failing to heal with this treatment, espec...
Autores principales: | Hayes, Paul D., Harding, Keith G., Johnson, Susan M., McCollum, Charles, Téot, Luc, Mercer, Kevin, Russell, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217204/ https://www.ncbi.nlm.nih.gov/pubmed/32103603 http://dx.doi.org/10.1111/iwj.13293 |
Ejemplares similares
-
Experience of ReCell in Skin Cancer Reconstruction
por: Gilleard, Onur, et al.
Publicado: (2013) -
Cost of managing patients with venous leg ulcers
por: Phillips, Ceri J., et al.
Publicado: (2020) -
Aspirin versus placebo for the treatment of venous leg ulcers—a phase II, pilot, randomised trial (AVURT)
por: Helen, Tilbrook, et al.
Publicado: (2019) -
Nonlinear modeling of venous leg ulcer healing rates
por: Cardinal, Matthew, et al.
Publicado: (2009) -
Non‐contact low‐frequency ultrasound therapy compared with UK standard of care for venous leg ulcers: a single‐centre, assessor‐blinded, randomised controlled trial
por: White, Judith, et al.
Publicado: (2015)